These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1269219)

  • 1. Plasma concentration of edrophonium in man.
    Calvey TN; Williams NE; Muir KT; Barber HE
    Clin Pharmacol Ther; 1976 Jun; 19(6):813-20. PubMed ID: 1269219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of (14C)-edrophonium in normal wistar rats and homozygous Gunn rats with ligated renal pedicles.
    Back DJ; Calvey TN
    Br J Pharmacol; 1974 May; 51(1):61-5. PubMed ID: 4216386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of edrophonium on erythrocyte acetylcholinesterase and neuromuscular function in the rat.
    Barber HE; Calvey TN; Muir KT; Taylor K
    Br J Pharmacol; 1976 Jan; 56(1):93-9. PubMed ID: 175874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The removal of 14 C-edrophonium from the circulation.
    Back DJ; Calvey TN
    Br J Pharmacol; 1972 Oct; 46(2):355-7. PubMed ID: 4651777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: The relation between the plasma concentration of edrophonium, inhibition of erythrocyte acetylcholinesterase, and the facilitation of neuromuscular function in the rat.
    Barber HE; Calvey TN; Muir KT; Taylor K
    Br J Pharmacol; 1975 Jun; 54(2):263P-264P. PubMed ID: 1148545
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of edrophonium in anephric and renal transplant patients.
    Morris RB; Cronnelly R; Miller RD; Stanski DR; Fahey MR
    Br J Anaesth; 1981 Dec; 53(12):1311-4. PubMed ID: 7032560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between the pharmacokinetics, cholinesterase inhibition and facilitation of twitch tension of the quaternary ammonium anticholinesterase drugs, neostigmine, pyridostigmine, edrophonium and 3-hydroxyphenyltrimethylammonium.
    Barber HE; Calvey TN; Muir KT
    Br J Pharmacol; 1979 Aug; 66(4):525-30. PubMed ID: 223706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excretion of 14 C-edrophonium and its metabolites in bile: role of the liver cell and the peribiliary vascular plexus.
    Back DJ; Calvey TN
    Br J Pharmacol; 1972 Mar; 44(3):534-43. PubMed ID: 5040663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacological effects of neostigmine in man.
    Calvey TN; Wareing M; Williams NE; Chan K
    Br J Clin Pharmacol; 1979 Feb; 7(2):149-55. PubMed ID: 216382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium.
    Miller DR; Bryson G; Martineau RJ; Kitts JB; Curran M; Bragg P; Watson JB; Hull K; Lindsay P
    Can J Anaesth; 1995 Nov; 42(11):996-1002. PubMed ID: 8590511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute intravenous and inhalation pharmacokinetics of 2,4-pentanedione in the Fischer 344 rat.
    Frantz SW; Ballantyne B; Leung HW
    Toxicol Ind Health; 1998; 14(3):413-28. PubMed ID: 9569447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Edrophonium: duration of action and atropine requirement in humans during halothane anesthesia.
    Cronnelly R; Morris RB; Miller RD
    Anesthesiology; 1982 Oct; 57(4):261-6. PubMed ID: 7125261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Priming with anti-cholinesterases--the effect of different priming doses of edrophonium.
    Naguib M; Abdulatif M
    Can J Anaesth; 1988 Jan; 35(1):53-7. PubMed ID: 3349555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma nicotine pharmacokinetics in dogs after intravenous administration: determination by radioimmunoassay.
    Monji N; Castro A
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):267-77. PubMed ID: 461952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detectable voice change with the edrophonium test in laryngeal myasthenia gravis.
    Tsunoda K; Fujimaki Y; Morita Y
    J Int Med Res; 2017 Oct; 45(5):1466-1469. PubMed ID: 28379106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
    Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
    Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of intravenous melphalan.
    Alberts DS; Chang SY; Chen HS; Moon TE; Evans TL; Furner RL; Himmelstein K; Gross JF
    Clin Pharmacol Ther; 1979 Jul; 26(1):73-80. PubMed ID: 445964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming with anti-cholinesterases--the effect of different combinations of anti-cholinesterases and different priming intervals.
    Naguib M; Abdulatif M
    Can J Anaesth; 1988 Jan; 35(1):47-52. PubMed ID: 3349554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.